You are here:

Home
NICE Guidance
Conditions and diseases
Blood and immune system conditions
Blood and bone marrow cancers

Blood and bone marrow cancers Products

A list of all our products on blood and bone marrow cancers

Filter

Product type

Product typeGuidanceQuality standardsAdvice

Guidance programme

Guidance programmeNICE guidelinesTechnology appraisal guidanceDiagnostics guidanceHealthTech guidanceInterventional procedures guidance

Status
1 selected

StatusPublishedIn consultationIn developmentAwaiting developmentTopic prioritisationDeferred

New and updated

New and updatedNew in the last 6 monthsUpdated in the last 6 months

Showing 1 product

Sort by: Date | Sort by Title

Status: DeferredRemove ‘Status: Deferred’ filter

Ciltacabtagene autoleucel for treating relapsed and lenalidomide-refractory multiple myeloma after 1 to 3 therapies [D5]
Status:
Deferred
Programme:
Technology appraisal guidance
Expected publication date:
TBC